Towards reducing resistance and haematological toxicity of linezolid [ 2004 - 2005 ]

Also known as: Ways of improving the use of a last-line antibiotic

Research Grant

[Cite as]

Researchers: Dr Craig Rayner (Principal investigator)

Brief description Multi-drug resistance in bacteria is increasing at an alarming rate. We have diminishing therapeutic options, and there are few antibiotics in the drug development pipeline that offer much hope. It is therefore important that we look towards ways of further optimising the use of antibiotics that we currently have available. An important last line of defense drug, linezolid, has been available in Australia for less than 2 years and already resistance is occuring. In addition, with broader use of this drug outside clinical trials, there has been an increasing concern over its toxicity to important blood cells. We seek to better understand the determinants of linezolid resistance and toxicity, so that novel dosing strategies may be developed to optimise its use (reduce toxicity and enhance efficacy) thereby extending the usefulness of this last line of defense antibiotic.

Funding Amount $AUD 135,825.00

Funding Scheme NHMRC Project Grants

Notes New Investigator Grant

Click to explore relationships graph
Viewed: [[ro.stat.viewed]]